SM
CCXI

SG3 Management’s ChemoCentryx, Inc. CCXI Stock Holding History

SG3 Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30,000
Closed -$743K – 503
2022
Q2 		$743K Buy
+30,000
New +$661K 0.09% 158
2022
Q1 		– Sell
-27,600
Closed -$1M – 1489
2021
Q4 		$1M Sell
27,600
-86,600
-76% -$3.04M 0.02% 480
2021
Q3 		$1.95M Sell
114,200
-23,300
-17% -$363K 0.06% 306
2021
Q2 		$1.84M Buy
137,500
+123,100
+855% +$3.03M 0.07% 328
2021
Q1 		$738K Sell
14,400
-15,600
-52% -$939K 0.02% 679
2020
Q4 		$1.86M Sell
30,000
-30,000
-50% -$1.72M 0.04% 405
2020
Q3 		$3.29M Buy
60,000
+35,000
+140% +$1.88M 0.12% 192
2020
Q2 		$1.44M Buy
+25,000
New +$1.36M 0.1% 235

Other funds holding CCXI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

SG3 Management's CCXI Position: Q3 2022 in Review

SG3 Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 4,000 shares — an estimated $99K sold.

SG3 Management first reported a position in CCXI in Q2 2020 and held it in 5 quarters. The position peaked at $1.1M in Q3 2020. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

  • SG3 Management reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
  • SG3 Management sold 4,000 ChemoCentryx, Inc. shares in Q3 2022, an estimated $99K.
  • SG3 Management first reported a position in ChemoCentryx, Inc. in Q2 2020 and held it in 5 quarters.
  • SG3 Management's ChemoCentryx, Inc. position peaked at $1.1M in Q3 2020.
  • 217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on SG3 Management's 13F filing for Q3 2022, filed 14 Nov 2022.